5 min read Company Profiles Featured Companies TC BioPharm (TCBP) initiates Phase 2b clinical trial of OmnImmune for treating Acute Myeloid Leukemia (AML). akchirpy November 22, 2022 TC Biopharm (NASDAQ: TCBP) (NASDAQ: TCBPW) today announced the dosing of its first three...Read More
